Corpus Intelligence IC Memo — WEST KENDALL BAPTIST HOSPITAL 2026-04-26 09:30 UTC
IC Memo — WEST KENDALL BAPTIST HOSPITAL
Investment Committee Memorandum | FL | 127 beds | Grade C | EBITDA uplift $26.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WEST KENDALL BAPTIST HOSPITAL

CCN 100314 | MIAMI-DADE, FL | 127 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WEST KENDALL BAPTIST HOSPITAL is a 127-bed suburban community hospital in MIAMI-DADE, FL with $361.6M in net patient revenue and a 18.5% operating margin. The hospital serves a payer mix of 16.6% Medicare, 2.3% Medicaid, and 81.1% commercial.

Thesis: Turnaround. Our ML models identify $26.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.5% to 25.8% (+736bps).

Net Revenue HCRIS$361.6M
Current EBITDA COMPUTED$66.8M
Operating Margin COMPUTED18.5%
Occupancy HCRIS84.4%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS22.5%
Distress Probability ML36.4%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
122
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 18.5% places it above the state median. Among 122 size-comparable peers (64-254 beds), the median margin is 4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (64-254), prioritizing same-state peers. 122 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WEST KENDALL BAPTIST HOSPITAL (Target)FL127$361.6M18.5%
MOFFITT CANCER CENTERFL218$1.91B16.0%
LARGO MEDICAL CENTERFL245$386.4M24.1%
HCA FL FT WALTON-DESTIN HOSPFL231$361.3M38.1%
ADVENTHEALTH WESLEY CHAPELFL169$360.1M17.0%
JUPITER MEDICAL CENTERFL242$333.2M-10.7%
ORLANDO HEALTH SOUTH LAKE HOSPFL167$331.8M7.2%
HCA FLORIDA WESTSIDE HOSPITALFL250$317.3M34.8%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.6M+210bp18mo
Cost to Collect4.5%2.5%$7.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.4M+122bp9mo
Clean Claim Rate88.0%96.0%$231K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.6M
Cost to Collect
$7.2M
Denial Rate Reduction
$7.2M
A/R Days Reduction
$4.4M
Clean Claim Rate
$231K
Total EBITDA Uplift$26.6M
Current EBITDA$66.8M
+ RCM Uplift+$26.6M
Pro Forma EBITDA$93.4M
Current Margin18.5%
Pro Forma Margin25.8%
WC Released (1x)$13.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$102.7M$706.6M6.88x47.1%
Base (11x exit)10.0x11.0x$102.7M$810.7M7.89x51.2%
Bull Case9.0x11.0x$92.5M$931.9M10.08x58.7%
Bull (12x exit)9.0x12.0x$92.5M$1.04B11.29x62.4%
Bear Case11.0x10.0x$113.0M$540.2M4.78x36.7%
Bear (11x exit)11.0x11.0x$113.0M$630.9M5.58x41.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 122 hospitals with 64-254 beds
  • Same-state prioritization (n=123)
  • Comp margins: P25=-5.5% / P50=4.8% / P75=15.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.